WASHINGTON – For the past six months, Congress seems to be sailing on the uncharacteristically slippery passage of a massive, multi-billion dollar bill to fund the Food and Drug Administration.
That all changed late last week when a powerful lawmaker, Sen. Richard Burr (R-N.C.), In opposition to the so-called user cost reauthorization bill came out of hand – and supported the entire committee process.
Unlock this article by subscribing to STAT + and enjoy your first 30 days for free!
Create a display name to comment
This name appears with your comment See the article : NBC Sports Washington premieres Off the Ice: Best of Capitals 2021-22.
